Amyris, Inc. (Emeryville, Calif.) announced that it will acquire Oobli Inc. (Davis, Calif.), a developer of fermentation-based sweet proteins used by food and beverage brands to reduce sugar without sacrificing taste. The acquisition is expected to close in the coming weeks.
Amyris, a vertically integrated biomanufacturing company, said the transaction brings together its scientific capabilities and manufacturing depth with Oobli's protein fermentation expertise.
The move follows Amyris' expansion of manufacturing capacity earlier this year at its advanced fermentation facility in Barra Bonita, Brazil. Amyris described the acquisition as a strategic commercial and technology expansion intended to accelerate its footprint in the protein- and peptide-based solution space across end markets.
Sweet proteins as a sugar-reduction tool
Oobli has spent the past decade refining a fermentation process to produce sweet proteins that occur naturally in rare fruits and berries found near the equator. According to the company, sweet proteins are hundreds to thousands of times sweeter than sugar, bind directly to sweet taste receptors and are metabolized by the body as protein, delivering sweetness without gut disruption or blood sugar spikes.
Its portfolio comprises Oubli Fruit, Serendipity Berry and Katemfe Fruit sweet proteins, known scientifically as brazzein, monellin and thaumatin. The ingredients hold FDA GRAS status as an ingredient and are FEMA GRAS-affirmed for use as a natural flavor. Amyris said growing consumer awareness of metabolic health and sugar reduction gives brands a tool applicable across sports nutrition, dairy, beverages, chocolate, bakery and confectionery.
“In Oobli, we see a commercial and technology platform that is a great complement to our own,” said Amyris chief executive officer Kathy Fortmann. She said Oobli is positioned to transform how sweetness reaches the market, and that combining its protein expertise with Amyris' strain engineering, manufacturing scale and commercial capabilities could broaden the company's reach in food and beverage, personal care, flavor and fragrances, agriculture and beyond.
Oobli's commercial portfolio of sweet proteins is expected to be the first to benefit from the combined platform. Oobli chief executive officer Ali Wing said the company had long believed there was a better way to deliver the sweet taste consumers want without trade-offs to health and the environment, and that joining Amyris provides the scale and resources to pursue its ambition of making sweet proteins a global standard in sweetness solutions.
Fortmann said biomanufactured solutions succeed when they align with consumer demand and market needs, and that Oobli's platform lets brands address sweet taste, sugar reduction and clean label at the same time. Amyris said all existing customer commitments and brand partnerships will continue to be honored without interruption as the portfolio expands within the company.
